Haleon
Haleon is a pure-play consumer health company selling over-the-counter medicines, oral care, supplements and skin health brands such as Sensodyne, Advil, Centrum and Voltaren to consumers across more than 170 markets, through pharmacy, retail, wholesale and digital channels.
- Company typePublic
- Founded2022
- HeadquartersLondon, United Kingdom
- Headcount10,001+
- GTM typeB2C
- OfferingHardware or Manufacturing
What Haleon does
Haleon is a pure-play consumer health company created in July 2022 as a standalone listed entity following its demerger from GlaxoSmithKline, with a premium listing on the London Stock Exchange and a NYSE listing (HLN) via sponsored ADRs. It is headquartered in Weybridge, UK, employs 10,000+ people, and sells branded over-the-counter medicines, oral care products, vitamins/minerals/supplements and therapeutic skin health products across more than 170 markets organised into five regions. Its portfolio spans six global categories - Oral Health, Vitamins, Minerals and Supplements, Pain Relief, Respiratory, Digestive Health and other, and Therapeutic Skin Health - built around nine Power Brands (Sensodyne, parodontax, Polident, Centrum, Emergen-C, Caltrate, Otrivin, Theraflu, Flonase, Robitussin, Voltaren, Panadol, Advil, Excedrin, Tums, Eno, Fenistil, Zovirax and Bactroban) plus local growth brands, and reaches 1.4 billion consumers with an ambition to reach one billion more by 2030.
The technical base is a consumer-health R&D and regulatory platform rather than a software platform: decades of testing, clinical trials and real-world-evidence studies, world-class regulatory and product-licence expertise, a new c.£200m R&D facility, and 127 product innovations reported in 2024. Haleon claims leadership in therapeutic oral health, backed by brands such as Sensodyne, parodontax and Polident, and it uses clinical evidence as a marketing asset - the 2026 Nature Medicine publication based on the COSMOS trial showing Centrum Silver may slow biological ageing in older adults. Product innovation in 2026 included Excedrin Rapid Relief (relief in as little as 15 minutes), the Centrum Age Defy multivitamin for adults 35+, Panacombo dual-action tablets and the Sensodyne Clinical Repair line. On the technology side Haleon is deploying AI agents feeding a "clean core" SAP operating model across machine, energy, supply chain and customer-experience data, and it has added AI/ML-adjacent commercial analytics around algorithms, loyalty and execution; there is no public developer API or partner-facing model access.
Revenue is generated from one-time branded product sales through retail, pharmacy, wholesale and digital channels rather than recurring subscriptions; pricing is not publicly disclosed. Route-to-market is built around direct relationships with pharmacists, shopper-experience tools, in-store category-growth execution programmes and pharmacist education, supported by an extensive field sales force, with mass-retail shelf placement (Walmart, Target) contested against Procter & Gamble and Colgate-Palmolive. The company operates 25 manufacturing sites (24 certified to the Alliance for Water Stewardship Standard), reports 100% satisfactory health authority inspections in 2025, and targets £800m of gross cost savings over five years from its standalone supply chain. FY2025 revenue was £11bn; H1 2026 revenue was £5.6bn with non-GAAP EPS of 10.30p and FY 2026 guidance reaffirmed, against a stated financial algorithm of 4-6% annual organic revenue growth with high-single-digit adjusted operating profit growth at constant currency in a c.£200bn consumer healthcare market.
Haleon firmographics
Firmographics- Name
- Haleon
- Legal name
- Haleon plc
- Website
- https://haleon.com
- Company type
- Public
- Founded year
- 2022
- Operating status
- Operating
- Headcount range
- 10,001+ employees
- Short description
- Haleon is a pure-play consumer health company selling over-the-counter medicines, oral care, supplements and skin health brands such as Sensodyne, Advil, Centrum and Voltaren to consumers across more than 170 markets, through pharmacy, retail, wholesale and digital channels.
- Ownership category
- akta.pro rank
Haleon industry classification
Industry- Product category
- Consumer Health / Over-the-Counter Medicines and Personal Care Products
- NAICS
- Drugs and Druggists' Sundries Merchant Wholesalers (42421), Drugs and Druggists' Sundries Merchant Wholesalers (4242), Drugs and Druggists' Sundries Merchant Wholesalers (424210)
- SIC
- Pharmaceutical Preparations (2834)
- akta.pro industry
- Cold, Flu, Cough & Allergy Remedies (Decongestants, Antihistamines, Cough Syrups, Lozenges)Consumer Products & Retail/Consumer Packaged Goods (CPG) Manufacturing & Brands/Health & Hygiene OTC Consumer Goods (First Aid, Oral Care, Personal Health)Dermatology OTC & Skin Health (Acne Treatments, Eczema/Psoriasis OTC, Antifungals, Wart Removal)Consumer Products & Retail/Consumer Packaged Goods (CPG) Manufacturing & Brands/Health & Hygiene OTC Consumer Goods (First Aid, Oral Care, Personal Health)Digestive Health OTC (Antacids, Laxatives, Anti-diarrheals, Probiotics OTC)Consumer Products & Retail/Consumer Packaged Goods (CPG) Manufacturing & Brands/Health & Hygiene OTC Consumer Goods (First Aid, Oral Care, Personal Health)Eye, Ear & Nasal Care OTC (Eye Drops, Ear Drops/Wax Removal, Saline Sprays)Consumer Products & Retail/Consumer Packaged Goods (CPG) Manufacturing & Brands/Health & Hygiene OTC Consumer Goods (First Aid, Oral Care, Personal Health)Sleep, Stress & Mood OTC (Sleep Aids, Melatonin OTC, Calm/Stress Relief)Consumer Products & Retail/Consumer Packaged Goods (CPG) Manufacturing & Brands/Health & Hygiene OTC Consumer Goods (First Aid, Oral Care, Personal Health)
Keywords
Where Haleon is headquartered
LocationHeadquarters
- HQ city
- London
- HQ country
- United Kingdom
- HQ region
- Europe
Offices31 records
Markets served
Haleon business model
Business model- GTM type
- B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Marketing or Sales, Technology or R&D, Personnel, Infrastructure
Revenue model
- Branded consumer health product sales (Oral Health, VMS, Pain Relief, Respiratory, Digestive Health, Therapeutic Skin Health): One-time sales of over-the-counter medicines, oral care products, vitamins/minerals/supplements and therapeutic skin health products through retail, pharmacy and other channels across 170+ markets. This is the core revenue engine (FY2025 revenue £11bn; H1 2026 revenue £5.6bn), driven by category leadership, brand recommendation by health professionals and innovation-led premiumisation rather than recurring subscription revenue.
- Distribution and route-to-market wholesale (including new rural distribution build-out): Revenue generated through selling branded products into wholesalers, pharmacy chains and mass retail, with expanded rural distribution in India (part of the £175m India investment) increasing access and volume throughput of oral health products.
Go-to-market motion4 records
Distribution channels5 records
Marketing channels9 records
Haleon product offering
Product offeringCore offering
Haleon manufactures and sells branded over-the-counter (OTC) medicines and consumer health products across six categories: Oral Health, Vitamins, Minerals and Supplements, Pain Relief, Respiratory, Digestive Health and other, and Therapeutic Skin Health. The portfolio is built around nine global Power Brands (Sensodyne, parodontax, Polident, Centrum, Emergen-C, Caltrate, Otrivin, Theraflu, Flonase, Voltaren, Panadol, Advil) plus local growth brands, sold through retail, pharmacy and wholesale channels in more than 170 markets. Haleon also operates the Haleon Health Partner digital portal for health professionals, an innovation portal and a supplier portal. FY2025 revenue was £11bn.
Product overview
Haleon is a pure-play consumer health company selling a portfolio of over-the-counter brands rather than a single software platform: it groups brands into six categories (Oral Health; Vitamins, Minerals and Supplements; Pain Relief; Respiratory; Digestive Health and other; Therapeutic Skin Health) built around nine Power Brands plus local growth brands. The Oral Health cluster is led by Sensodyne (sensitivity toothpaste/mouthwash), parodontax (gum health) and Polident (denture care), supported by Aquafresh, Biotene and Corsodyl; the VMS cluster by Centrum (multivitamins/minerals, e.g. Centrum Age Defy), Caltrate (calcium) and Emergen-C (vitamin C); Pain Relief by Panadol, Advil, Fenbid, Voltaren, Excedrin, Contac and Grand-pa; Respiratory by Otrivin, Theraflu, Flonase and Robitussin; Digestive Health by Tums, Eno, Benefiber and Alli; and Therapeutic Skin Health by Fenistil, Zovirax, Bactroban, Zovirax Duo and Chapstick/Abreva. Alongside these physical consumer brands Haleon operates related digital services and platforms, including the Haleon Health Partner portal for health professionals, an Innovation Portal, a Supplier Portal, investor Share Price Tools, the haleon.help consumer relations and adverse-event reporting service, and a Safety Data Sheets portal.
Differentiator
Problem solved
Functional benefit
Brands
- Sensodyne: Oral health brand (toothpaste) for sensitive teeth; a leading Power Brand.
- parodontax
- Polident
- Centrum
- Emergen-C
- Caltrate
- Otrivin
- Theraflu
- Flonase
- Robitussin
- Voltaren
- Panadol
- Advil
- Fenbid
- Contac
- Grand-pa
- Excedrin
- Benefiber
- Tums
- Eno
- Fenistil
- Zovirax
- Bactroban
Products and services
- Sensodyne Specialist sensitivity toothpaste and mouthwash brand positioned at the forefront of Haleon's therapeutic oral health category, including Sensodyne Repair and Clinical Repair variants and mouthwash line extensions.
- parodontax Therapeutic gum-health toothpaste and mouthwash brand (parodontax Active Gum Health) being expanded in China with local flavours to meet rising gum-health demand.
- Polident Brand of daily dental appliance cleaners for denture care, including overnight whitening tablet formats, within Haleon's oral health portfolio.
- Aquafresh Oral care brand (toothpaste, toothbrushes including the 1998 flex neck brush) within Haleon's oral health portfolio.
- Biotene Oral care brand acquired in 2008, including moisturising mouthwash for dry mouth.
- Corsodyl Oral care brand launched as a gel and mouthwash in 1975, acquired by SmithKline Beecham in 1993.
- Centrum Category-leading multivitamin and mineral brand available in more than 70 markets, with variants such as Centrum MEN Multi-Gummies and the Centrum Age Defy multivitamin for adults 35+.
- Emergen-C Vitamin C immune support brand in crystals and effervescent formulations, extended through a 'Drink of the Summer' campaign and mocktail collaboration with Carl Radke's Soft Bar.
- Caltrate Leading calcium supplement brand within Haleon's vitamins, minerals and supplements category, now with double vitamin D3 formulations.
- Otrivin Nasal decongestant brand used to clear blocked noses, part of Haleon's cold and flu, decongestant and allergy portfolio.
- Theraflu Multi-symptom cold and flu treatment brand addressing fever, nasal congestion and cough (e.g. Theraflu Flu Relief Max Strength).
- Flonase Nasal allergy relief spray brand (Flonase Sensimist Allergy Relief Spray) in Haleon's respiratory health category.
- Robitussin Cough remedy brand including long-acting cough soft chews, within Haleon's leading respiratory portfolio.
- Voltaren Topical anti-inflammatory gel and arthritis pain gel brand (e.g. Voltaren Sport gel, Arthritis Pain Gel) used in sports, golf and UEFA Champions League licensed campaigns.
- Panadol World-leading paracetamol-based pain relief brand (Panadol Advance 500mg) serving as a global flagship of Haleon's pain relief portfolio.
- Advil Ibuprofen pain relief brand including liquid gels and minis formats, originating from the 1984 launch and now a core global Haleon brand.
- Fenbid Ibuprofen pain relief brand also sold in chewable format, launched in 1983 (as Solpaflex in some markets).
- Contac Pain and cold remedy brand in Haleon's pain relief portfolio.
- Grand-pa Headache powder brand sold in stick-pack formats within Haleon's pain relief range.
- Excedrin Headache relief brand (Excedrin Extra Strength) now marketed with a Rapid Relief claim of relief in as little as 15 minutes and a digital pet experience campaign.
- Tums Antacid brand with chewy bites and tablet formats for heartburn and acid indigestion.
- Eno Antacid brand (Eno Blue) with heritage in treating heartburn, acid indigestion and gastric discomfort.
- Benefiber Prebiotic fibre supplement brand sold in gummy format within Haleon's digestive health portfolio.
- Fenistil Soothing antihistamine brand (including drops) for skin allergy conditions in Haleon's therapeutic skin health category.
- Zovirax Cold sore cream brand with duo and single-tube variants for cold sore treatment.
- Bactroban Topical antibiotic ointment brand for bacterial skin infections.
- Abreva Cold sore treatment brand in Haleon's therapeutic skin health category.
- Haleon Health Partner portal Digital portal for health professionals providing clinical and consumer education resources to support recommendation of Haleon brands; it grew to 39 markets and supported over 52 million individuals in the 2025 reporting period.
Quantifiable outcome
- 74 million+ people empowered to be more included in opportunities for better everyday health in the 2025 reporting period (1 Dec 2024-30 Nov 2025), surpassing the goal set in 2022
- +8 more outcomes
Companies that use Haleon
Customer profileNamed customers3 records
Segments5 records
Ideal customer profiles4 records
Haleon technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration1 record
AI capability4 records
Feature6 records
Haleon partnerships and signals
Strategic signalPartnerships
16 partnerships are on record, tiered core, minor and flagship.
- Singapore Agency for Science, Technology and Research (A*STAR)coreHaleon and A*STAR launched a new clinical study on women's metabolic health in Asia. The study extends Haleon's scientific evidence base in the region and supports the company's VMS and self-care portfolio with clinical data.
- Carl Radke's Soft BarminorEmergen-C partnered with Carl Radke's Soft Bar to become the 'Drink of the Summer', making everyday wellness a refreshing summer ritual. The collaboration pairs a Haleon supplement brand with a non-alcoholic beverage brand for co-marketing and consumer trial.
- Soft BarminorReported as Haleon partnering with Soft Bar for Emergen-C mocktails, extending the 'Drink of the Summer' activation to mocktail occasions.
- UEFA MedicalflagshipHaleon became UEFA Medical's first Health Partner in a multi-year scientific partnership. The collaboration advances evidence-based topical pain management, recovery and athlete health across football and sport, linking Haleon's Voltaren topical portfolio with UEFA's medical programme.
- UEFA Champions League (UC3)flagshipVoltaren, produced by Haleon, announced a two-year partnership under which its products become Official UEFA Champions League Licensed Products for the 2025/26 and 2026/27 seasons. The deal uses football audiences to keep fans moving and support topical pain relief demand.
- Schneider ElectricminorListed among Haleon's key collaborations in its Health Inclusivity and Sustainability framework, supporting decarbonisation of pharma supply chains alongside other industry partners.
- Johnson ControlsminorNamed as a key collaboration in Haleon's Health Inclusivity and Sustainability framework, linked to decarbonising pharma supply chains and energy efficiency of manufacturing operations.
- ZeroRouteminorIncluded in Haleon's key collaborations section for its Health Inclusivity and Sustainability strategy, contributing to value-chain resilience and supply-chain emissions initiatives.
- WRAPminorKey collaboration supporting Haleon's packaging and recycled-content sustainability goals, including making packaging recycle-ready and reducing virgin petroleum-based plastic.
- Consumer Goods ForumminorIndustry body Haleon works with on sustainability and health inclusivity initiatives; Haleon's CEO Brian McNamara also serves as a Board Member of the Consumer Goods Forum.
- Ellen MacArthur FoundationminorNamed in Haleon's key collaborations, supporting circular-economy and sustainable sourcing work in the Health Inclusivity and Sustainability framework.
- Forum for the FutureminorKey collaboration in Haleon's Health Inclusivity and Sustainability strategy, contributing to long-term resilience and sustainability of the value chain.
- BSRminorNamed in Haleon's key collaborations for social and human-rights standards across its people, suppliers and partners.
- Action for Sustainable DerivativesminorKey collaboration supporting Haleon's sustainable sourcing of ingredients and deforestation-free key materials.
- EnergizeminorKey collaboration listed by Haleon in the Health Inclusivity and Sustainability framework, associated with energy and emissions reduction activity across operations.
- CIPPAminorKey collaboration within Haleon's Health Inclusivity and Sustainability framework, linked to packaging and resource-efficiency programmes.
Scale indicators24 records
Recent moves11 records
Expansion highlights10 records
Haleon competitors and assessment
Company assessmentDirect peers
- Kenvue: Spun out of Johnson & Johnson in 2023 as a pure-play consumer health company (Tylenol, Listerine, Neutrogena, Band-Aid), it is the closest listed structural analogue to Haleon with the same OTC/consumer-health model, pharmacy-led route to market and global brand portfolio.
- Reckitt: UK-listed consumer health company behind Dettol, Strepsils and Nurofen, combining OTC medicines, consumer health and hygiene brands sold through the same global pharmacy and retail channels as Haleon.
- Prestige Consumer Healthcare: North America-focused OTC portfolio company (Crest, Clear Eyes, Chloraseptic, Halls) built through brand acquisitions with a comparable branded consumer health route-to-market, though narrower geography and category mix.
- Church & Dwight: Owns OTC consumer health brands (First Aid, Advil competitor brands such as Advil alternatives, Orajel, Summer's Eve) sold through pharmacy and mass retail, competing with Haleon's pain relief and therapeutic skin health franchises in the same US channels.
Broad incumbents
- Procter & Gamble: Owner of Crest and Oral-B and a stated competitor for Haleon's shelf space in oral care, plus Vicks for cold/flu; it is the large diversified incumbent competing most directly with Haleon in Haleon's lead category.
- Colgate-Palmolive: Global oral care leader (Colgate, Total, Elmex) and the other principal toothpaste/mouthwash competitor to Haleon's Sensodyne, parodontax and Polident brands in the mass-retail channel.
- Sanofi: Owner of consumer health brands (Vicks, children's Tylenol, allergy brands) alongside a larger prescription pharmaceutical business, so it overlaps with Haleon in OTC while retaining broader pharma exposure.
- Bayer: Operates a large consumer health division (Aspirin, Rennie, Clarityne) that overlaps with Haleon's pain relief and digestive health franchises, within a broader pharma, crop science and consumer health group.
- Johnson & Johnson: Former owner of the consumer health business now listed as Kenvue, with remaining OTC participation through brands such as Tylenol; a broad incumbent in the same self-care and pharmacy channel.
Others
- Grifols: Not a branded-OTC competitor, but a relevant adjacent consumer-health/biologics participant; useful as a comparison point for consumer health companies with heavy manufacturing footprint and regulatory burden.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat7 records
Key risks7 records
Key highlights7 records
Customer concentration
Haleon social profiles
Digital presenceHaleon financial estimates
Financial estimateRevenue estimate
Valuation estimate
Haleon leadership team
Management profileNumber of profiles
Profiles33 records
Haleon subsidiaries and ownership
Company hierarchySubsidiaries8 records
Haleon funding detail
Funding detailFunding overview
Funding rounds1 record
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Haleon M&A and investment
M&A and investmentM&A1 record
Investments2 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Haleon
What does Haleon do?
Haleon manufactures and sells branded over-the-counter (OTC) medicines and consumer health products across six categories: Oral Health, Vitamins, Minerals and Supplements, Pain Relief, Respiratory, Digestive Health and other, and Therapeutic Skin Health. The portfolio is built around nine global Power Brands (Sensodyne, parodontax, Polident, Centrum, Emergen-C, Caltrate, Otrivin, Theraflu, Flonase, Voltaren, Panadol, Advil) plus local growth brands, sold through retail, pharmacy and wholesale channels in more than 170 markets. Haleon also operates the Haleon Health Partner digital portal for health professionals, an innovation portal and a supplier portal. FY2025 revenue was £11bn.
Is Haleon a public or private company?
Haleon is a public company. It is classified as public and is currently operating.
When was Haleon founded?
Haleon was founded in 2022. It employs 10,001+ people.
Where is Haleon based?
Haleon is headquartered in London, United Kingdom, in the Europe region.
How does Haleon make money?
Two revenue lines are on record. Branded consumer health product sales (Oral Health, VMS, Pain Relief, Respiratory, Digestive Health, Therapeutic Skin Health) is the primary driver. The others are distribution and route-to-market wholesale (including new rural distribution build-out).
Who are Haleon's main competitors?
Direct peers on record are Kenvue, Reckitt, Prestige Consumer Healthcare and Church & Dwight. Broad incumbents are Procter & Gamble, Colgate-Palmolive, Sanofi, Bayer and Johnson & Johnson. Grifols is listed as an others.
Does Haleon have an API?
No public API is recorded for Haleon.
What industry is Haleon in?
Haleon's product category is Consumer Health / Over-the-Counter Medicines and Personal Care Products. Its primary akta.pro industry code is CRADAMAD, Cold, Flu, Cough & Allergy Remedies (Decongestants, Antihistamines, Cough Syrups, Lozenges), with a secondary code of CRADAMAF, Dermatology OTC & Skin Health (Acne Treatments, Eczema/Psoriasis OTC, Antifungals, Wart Removal). Its NAICS code is 42421 and its SIC code is 2834.